The George Institute

This large global trial tested whether a low dose of the blood-thinning drug rivaroxaban could reduce serious heart problems in people with advanced kidney disease or on dialysis who also have high cardiovascular risk. About 1,753 participants were randomly assigned to receive ei…

This study tested two different ways of giving electroconvulsive therapy (ECT) to people with severe depression. Researchers wanted to see if placing the electrodes in a different spot on the head (frontoparietal) works as well as the standard spot (temporoparietal) but causes fe…

This study tested whether a digital health program on tablets could help community health workers better screen and manage health risks for pregnant women in rural India. Over 3,400 women participated to see if the program could reduce anemia and improve follow-up care for high b…

This large international trial tested whether a combination of three low-dose blood pressure medicines (a 'Triple Pill') could prevent a second stroke in people who had already survived a serious type of stroke caused by bleeding in the brain. Over 1,600 participants were randoml…

This international study followed 6,000 people with kidney disease to better understand how the disease progresses over time. Researchers collected routine medical information from patients' regular doctor visits to identify patterns in kidney function decline. The study also aim…